SKA3 and cholangiocarcinoma: Although previous studies have reported that SKA3 interacted with PARP1/HIF-1α to promote cholangiocarcinoma proliferation [23], our findings did not reveal a direct interaction between SKA3 and HIF-1α in LUAD.